Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
ACCELERON PHARMA INC (XLRN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/24/2021 |
SC 13D/A
| Avoro Capital Advisors LLC reports a 0% stake in Acceleron Pharma Inc. |
| 11/22/2021 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 34,499 shares
@ $0
Disposed/sold 10,000 options to buy
@ $27.97, valued at
$279.7k
Disposed/sold 7,500 options to buy
@ $30.17, valued at
$226.3k
Disposed/sold 7,500 options to buy
@ $40.61, valued at
$304.6k
Disposed/sold 10,000 options to buy
@ $41.2, valued at
$412k
Disposed/sold 7,500 options to buy
@ $41.64, valued at
$312.3k
Disposed/sold 8,185 options to buy
@ $52.99, valued at
$433.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 11/22/2021 |
4
| Malik Kemal (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 1,622 shares
@ $0
Disposed/sold 17,956 options to buy
@ $52.61, valued at
$944.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 11/22/2021 |
4
| Hite Christopher (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 930 shares
@ $0
Disposed/sold 10,267 options to buy
@ $92.09, valued at
$945.5k
Disposed/sold 1,848 options to buy
@ $115.53, valued at
$213.5k
|
|
| 11/22/2021 |
4
| Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 1,622 shares
@ $0
Disposed/sold 10,000 options to buy
@ $35.34, valued at
$353.4k
Disposed/sold 1,875 options to buy
@ $40.61, valued at
$76.1k
Disposed/sold 3,750 options to buy
@ $41.64, valued at
$156.2k
Disposed/sold 4,085 options to buy
@ $52.99, valued at
$216.5k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 11/22/2021 |
4
| MCCOURT Thomas A (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 6,044 shares
@ $0
Disposed/sold 7,500 options to buy
@ $41.64, valued at
$312.3k
Disposed/sold 8,185 options to buy
@ $52.99, valued at
$433.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 11/22/2021 |
4
| Kearney Terrence C (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 6,749 shares
@ $0
Disposed/sold 7,500 options to buy
@ $40.61, valued at
$304.6k
Disposed/sold 4,665 options to buy
@ $41.2, valued at
$192.2k
Disposed/sold 7,500 options to buy
@ $41.64, valued at
$312.3k
Disposed/sold 8,185 options to buy
@ $52.99, valued at
$433.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 11/22/2021 |
4
| Hamill Laura (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 474 shares
@ $0
Disposed/sold 9,339 options to buy
@ $101.88, valued at
$951.5k
Disposed/sold 941 options to buy
@ $115.53, valued at
$108.7k
|
|
| 11/22/2021 |
4
| Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 6,749 shares
@ $0
Disposed/sold 10,000 options to buy
@ $27.97, valued at
$279.7k
Disposed/sold 7,500 options to buy
@ $30.17, valued at
$226.3k
Disposed/sold 10,000 options to buy
@ $34.14, valued at
$341.4k
Disposed/sold 7,500 options to buy
@ $40.61, valued at
$304.6k
Disposed/sold 576 options to buy
@ $41.2, valued at
$23.7k
Disposed/sold 20,000 options to buy
@ $41.48, valued at
$829.6k
Disposed/sold 7,500 options to buy
@ $41.64, valued at
$312.3k
Disposed/sold 8,185 options to buy
@ $52.99, valued at
$433.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 11/22/2021 |
4
| Veness Adam M (SVP, General Counsel and Sec.) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 23,423 shares
@ $0
Disposed/sold 6,700 options to buy
@ $40.37, valued at
$270.5k
Disposed/sold 7,650 options to buy
@ $40.61, valued at
$310.7k
Disposed/sold 8,500 options to buy
@ $41.64, valued at
$353.9k
Disposed/sold 24,334 options to buy
@ $52.99, valued at
$1.3M
Disposed/sold 18,806 options to buy
@ $115.53, valued at
$2.2M
|
|
| 11/22/2021 |
4
| KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 18,509 shares
@ $0
Disposed/sold 25,000 options to buy
@ $40.61, valued at
$1M
Disposed/sold 25,500 options to buy
@ $41.64, valued at
$1.1M
Disposed/sold 24,334 options to buy
@ $52.99, valued at
$1.3M
Disposed/sold 20,896 options to buy
@ $115.53, valued at
$2.4M
|
|
| 11/22/2021 |
4
| Backstrom Jay T. (EVP, Research and Development) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 21,233 shares
@ $0
Disposed/sold 96,963 options to buy
@ $52.61, valued at
$5.1M
Disposed/sold 20,896 options to buy
@ $115.53, valued at
$2.4M
|
|
| 11/22/2021 |
4
| MCLAUGHLIN KEVIN F (SVP, CFO and Treasurer) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 10,681 shares
@ $0
Disposed/sold 2,663 options to buy
@ $30.17, valued at
$80.3k
Disposed/sold 11,262 options to buy
@ $40.61, valued at
$457.3k
Disposed/sold 20,500 options to buy
@ $41.64, valued at
$853.6k
Disposed/sold 24,334 options to buy
@ $52.99, valued at
$1.3M
Disposed/sold 18,806 options to buy
@ $115.53, valued at
$2.2M
|
|
| 11/22/2021 |
4
| Dable Habib J (CEO and President) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 98,450 shares
@ $0
Disposed/sold 250,000 options to buy
@ $35.04, valued at
$8.8M
Disposed/sold 108,800 options to buy
@ $40.61, valued at
$4.4M
Disposed/sold 106,400 options to buy
@ $41.64, valued at
$4.4M
Disposed/sold 84,720 options to buy
@ $52.99, valued at
$4.5M
Disposed/sold 64,361 options to buy
@ $115.53, valued at
$7.4M
|
|
| 11/22/2021 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 11/22/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/22/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/22/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/17/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/17/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/17/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/12/2021 |
4
| Veness Adam M (SVP, General Counsel and Sec.) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Exercised 4,500 options to buy
@ $29.37, valued at
$132.2k
|
|
| 11/12/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/10/2021 |
SC 13G/A
| FMR LLC reports a 0.8% stake in ACCELERON PHARMA INC |
| 11/10/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/08/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/08/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/04/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/04/2021 |
8-K
| Quarterly results |
| 10/29/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/29/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/28/2021 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/27/2021 |
8-K
| Results of Operations and Financial Condition Interactive Data |
|
|
|